Logo image of NVST

ENVISTA HOLDINGS CORP (NVST) Stock Fundamental Analysis

NYSE:NVST - New York Stock Exchange, Inc. - US29415F1049 - Common Stock - Currency: USD

17.7  +0.86 (+5.11%)

Fundamental Rating

4

NVST gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. NVST has an average financial health and profitability rating. NVST has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

NVST had positive earnings in the past year.
NVST had a positive operating cash flow in the past year.
In multiple years NVST reported negative net income over the last 5 years.
NVST had a positive operating cash flow in each of the past 5 years.
NVST Yearly Net Income VS EBIT VS OCF VS FCFNVST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -20.57%, NVST is in line with its industry, outperforming 51.32% of the companies in the same industry.
The Return On Equity of NVST (-37.03%) is comparable to the rest of the industry.
The Return On Invested Capital of NVST (2.59%) is better than 71.43% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NVST is below the industry average of 7.71%.
Industry RankSector Rank
ROA -20.57%
ROE -37.03%
ROIC 2.59%
ROA(3y)-6.24%
ROA(5y)-2.61%
ROE(3y)-11.58%
ROE(5y)-5.09%
ROIC(3y)4.17%
ROIC(5y)4.15%
NVST Yearly ROA, ROE, ROICNVST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

NVST has a Operating Margin of 6.01%. This is in the better half of the industry: NVST outperforms 73.02% of its industry peers.
NVST's Operating Margin has declined in the last couple of years.
The Gross Margin of NVST (54.77%) is comparable to the rest of the industry.
NVST's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.01%
PM (TTM) N/A
GM 54.77%
OM growth 3Y-26.92%
OM growth 5Y-10.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-1.29%
NVST Yearly Profit, Operating, Gross MarginsNVST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NVST is destroying value.
NVST has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NVST has been increased compared to 5 years ago.
The debt/assets ratio for NVST is higher compared to a year ago.
NVST Yearly Shares OutstandingNVST Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NVST Yearly Total Debt VS Total AssetsNVST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

NVST has an Altman-Z score of 1.35. This is a bad value and indicates that NVST is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.35, NVST perfoms like the industry average, outperforming 56.08% of the companies in the same industry.
The Debt to FCF ratio of NVST is 5.27, which is a neutral value as it means it would take NVST, 5.27 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NVST (5.27) is better than 79.89% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that NVST is not too dependend on debt financing.
NVST has a Debt to Equity ratio (0.43) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 5.27
Altman-Z 1.35
ROIC/WACC0.37
WACC6.93%
NVST Yearly LT Debt VS Equity VS FCFNVST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

NVST has a Current Ratio of 2.12. This indicates that NVST is financially healthy and has no problem in meeting its short term obligations.
NVST has a worse Current ratio (2.12) than 64.02% of its industry peers.
A Quick Ratio of 1.82 indicates that NVST should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.82, NVST is in line with its industry, outperforming 45.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.82
NVST Yearly Current Assets VS Current LiabilitesNVST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

4

3. Growth

3.1 Past

NVST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.65%.
The earnings per share for NVST have been decreasing by -28.29% on average. This is quite bad
The Revenue has decreased by -2.30% in the past year.
Measured over the past years, NVST shows a small growth in Revenue. The Revenue has been growing by 1.90% on average per year.
EPS 1Y (TTM)-49.65%
EPS 3Y-28.29%
EPS 5YN/A
EPS Q2Q%-7.69%
Revenue 1Y (TTM)-2.3%
Revenue growth 3Y0.02%
Revenue growth 5Y1.9%
Sales Q2Q%-1.07%

3.2 Future

Based on estimates for the next years, NVST will show a very strong growth in Earnings Per Share. The EPS will grow by 33.46% on average per year.
Based on estimates for the next years, NVST will show a small growth in Revenue. The Revenue will grow by 7.74% on average per year.
EPS Next Y38.52%
EPS Next 2Y26.34%
EPS Next 3Y21.25%
EPS Next 5Y33.46%
Revenue Next Year0.55%
Revenue Next 2Y1.84%
Revenue Next 3Y2.26%
Revenue Next 5Y7.74%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVST Yearly Revenue VS EstimatesNVST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
NVST Yearly EPS VS EstimatesNVST Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

NVST is valuated rather expensively with a Price/Earnings ratio of 24.93.
Based on the Price/Earnings ratio, NVST is valued a bit cheaper than 78.84% of the companies in the same industry.
NVST is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 23.99, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 15.19 indicates a correct valuation of NVST.
Based on the Price/Forward Earnings ratio, NVST is valued cheaply inside the industry as 82.54% of the companies are valued more expensively.
NVST's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.35.
Industry RankSector Rank
PE 24.93
Fwd PE 15.19
NVST Price Earnings VS Forward Price EarningsNVST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NVST is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
94.71% of the companies in the same industry are more expensive than NVST, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.2
EV/EBITDA 11.84
NVST Per share dataNVST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

NVST's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NVST's earnings are expected to grow with 21.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.65
PEG (5Y)N/A
EPS Next 2Y26.34%
EPS Next 3Y21.25%

More info and screens

0

5. Dividend

5.1 Amount

NVST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENVISTA HOLDINGS CORP

NYSE:NVST (5/8/2025, 11:03:02 AM)

17.7

+0.86 (+5.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners114.26%
Inst Owner Change2.16%
Ins Owners0.63%
Ins Owner Change7.07%
Market Cap3.00B
Analysts71
Price Target19.84 (12.09%)
Short Float %6.64%
Short Ratio3.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.08%
Min EPS beat(2)7.34%
Max EPS beat(2)14.82%
EPS beat(4)3
Avg EPS beat(4)-1.98%
Min EPS beat(4)-59.95%
Max EPS beat(4)29.88%
EPS beat(8)4
Avg EPS beat(8)-6.09%
EPS beat(12)6
Avg EPS beat(12)-4.53%
EPS beat(16)10
Avg EPS beat(16)-1.17%
Revenue beat(2)0
Avg Revenue beat(2)-0.58%
Min Revenue beat(2)-0.9%
Max Revenue beat(2)-0.26%
Revenue beat(4)0
Avg Revenue beat(4)-1.35%
Min Revenue beat(4)-4.06%
Max Revenue beat(4)-0.18%
Revenue beat(8)0
Avg Revenue beat(8)-2.02%
Revenue beat(12)0
Avg Revenue beat(12)-2.08%
Revenue beat(16)1
Avg Revenue beat(16)-2.89%
PT rev (1m)-4.22%
PT rev (3m)-4.02%
EPS NQ rev (1m)-1.26%
EPS NQ rev (3m)-17.63%
EPS NY rev (1m)-0.15%
EPS NY rev (3m)-12.16%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)-3.56%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-1.98%
Valuation
Industry RankSector Rank
PE 24.93
Fwd PE 15.19
P/S 1.2
P/FCF 11.2
P/OCF 10.12
P/B 0.99
P/tB 36.36
EV/EBITDA 11.84
EPS(TTM)0.71
EY4.01%
EPS(NY)1.17
Fwd EY6.58%
FCF(TTM)1.58
FCFY8.93%
OCF(TTM)1.75
OCFY9.88%
SpS14.77
BVpS17.92
TBVpS0.49
PEG (NY)0.65
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.57%
ROE -37.03%
ROCE 3.27%
ROIC 2.59%
ROICexc 3.38%
ROICexgc 21.13%
OM 6.01%
PM (TTM) N/A
GM 54.77%
FCFM 10.7%
ROA(3y)-6.24%
ROA(5y)-2.61%
ROE(3y)-11.58%
ROE(5y)-5.09%
ROIC(3y)4.17%
ROIC(5y)4.15%
ROICexc(3y)4.97%
ROICexc(5y)5.02%
ROICexgc(3y)81.26%
ROICexgc(5y)N/A
ROCE(3y)5.28%
ROCE(5y)5.25%
ROICexcg growth 3Y-55.07%
ROICexcg growth 5Y-3.56%
ROICexc growth 3Y-21.01%
ROICexc growth 5Y-0.5%
OM growth 3Y-26.92%
OM growth 5Y-10.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-1.29%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 5.27
Debt/EBITDA 4.81
Cap/Depr 24.14%
Cap/Sales 1.15%
Interest Coverage 2.93
Cash Conversion 110.1%
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 1.82
Altman-Z 1.35
F-Score4
WACC6.93%
ROIC/WACC0.37
Cap/Depr(3y)41.77%
Cap/Depr(5y)41.11%
Cap/Sales(3y)2.19%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.65%
EPS 3Y-28.29%
EPS 5YN/A
EPS Q2Q%-7.69%
EPS Next Y38.52%
EPS Next 2Y26.34%
EPS Next 3Y21.25%
EPS Next 5Y33.46%
Revenue 1Y (TTM)-2.3%
Revenue growth 3Y0.02%
Revenue growth 5Y1.9%
Sales Q2Q%-1.07%
Revenue Next Year0.55%
Revenue Next 2Y1.84%
Revenue Next 3Y2.26%
Revenue Next 5Y7.74%
EBIT growth 1Y-50.44%
EBIT growth 3Y-26.9%
EBIT growth 5Y-8.72%
EBIT Next Year46.96%
EBIT Next 3Y19.61%
EBIT Next 5Y29.05%
FCF growth 1Y145.91%
FCF growth 3Y-0.46%
FCF growth 5Y-1.09%
OCF growth 1Y62.64%
OCF growth 3Y-2.37%
OCF growth 5Y-3.28%